Skip to main content
Affiliate disclosureWe earn a commission if you buy through links on this page, at no extra cost to you. Read our methodology →
HerbClinical dose · 100–150mg/day (150mg is the highest dose tested in humans; 200mg has never been tested)Onset · Subjective effects measured 1–3 hours after dosing; onset speed has not been tested directly

Dynamine (Methylliberine)

Only three human RCTs have tested methylliberine. The only one measuring cognition with methylliberine alone (La Monica et al., 2023, n=25, 100mg/day) found better self-rated concentration, motivation, mood and energy, but a negligible effect on objective cognitive tests (Stroop, Trail Making B). A 4-week safety trial (VanDusseldorp et al., 2020, n=125, 100–150mg/day) found no clinically significant cardiovascular or blood changes; it did not test cognition. A third trial (Cintineo 2022) tested it only inside a caffeine + theacrine combination. Both methylliberine-specific trials were funded in whole or part by Compound Solutions, which sells Dynamine, and a La Monica co-author holds patents on methylliberine.

By The Nootropic Lab editorial teamUpdated 8 min read✓ Fact-checked

Evidence reviewed:

Mechanism of action

Dynamine (methylliberine) is a purine alkaloid found in kucha tea leaves, structurally related to caffeine and theacrine. It is described as blocking adenosine receptors (like caffeine) and inhibiting phosphodiesterase. In a 4-week trial at 100–150mg/day it produced no clinically significant changes in heart rate, blood pressure or blood biomarkers. No study has measured tolerance.

Clinical evidence summary

Only three human RCTs have tested methylliberine. The only one measuring cognition with methylliberine alone (La Monica et al., 2023, n=25, 100mg/day) found better self-rated concentration, motivation, mood and energy, but a negligible effect on objective cognitive tests (Stroop, Trail Making B). A 4-week safety trial (VanDusseldorp et al., 2020, n=125, 100–150mg/day) found no clinically significant cardiovascular or blood changes; it did not test cognition. A third trial (Cintineo 2022) tested it only inside a caffeine + theacrine combination. Both methylliberine-specific trials were funded in whole or part by Compound Solutions, which sells Dynamine, and a La Monica co-author holds patents on methylliberine.

Human effect matrix

Based on human clinical trials only. Animal and in-vitro data excluded.

EffectEvidenceMagnitudeStudies
Subjective Energy preliminary
Moderate
1
Focus & Motivation mixed
Small
1
Cardiovascular Safety moderate
Negligible
1

Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results

Documented benefits

  • Better self-rated energy, mood and motivation (one small RCT)
  • No clinically significant heart rate or blood pressure change over 4 weeks at 100–150mg

Side effects & cautions

  • Limited safety data: three human RCTs, both methylliberine-specific trials funded by the manufacturer
  • Objective cognition: no measurable effect on Stroop or Trail Making tests in the only trial that tested it
  • Mild GI discomfort possible
  • Possible interaction with caffeine (additive stimulation)
  • Not recommended during pregnancy (precautionary: no pregnancy data)

How to take

Dosage100–150mg/day — no human trial has tested more than 150mg
TimingAs needed, before tasks. The trial measured effects over the 3 hours after dosing; effects on sleep have not been studied.
With foodCan be taken with or without food.
FormsCapsule. Dynamine is a trademarked ingredient from Compound Solutions. Not available as a standalone consumer product — found only in pre-formulated stacks like Thesis.

Stacking recommendations

Ingredients that pair well with Dynamine (Methylliberine) and why.

A common pairing in pre-formulated stacks. In tactical personnel, 150mg caffeine + 100mg methylliberine + 50mg theacrine matched 300mg caffeine on vigilance reaction time with a smaller diastolic blood pressure rise (Cintineo 2022) — but that tests the combination, not Dynamine alone.

L-Theanine is commonly paired with stimulants for calmer focus, though in a controlled caffeine trial it did not significantly reduce jitteriness, and the combination with Dynamine has not been tested.

Dynamine provides acute adenosine blockade; Zynamite extends dopamine via COMT inhibition. Together found in Thesis blends for multi-pathway stimulation.

Frequently asked questions

How is Dynamine different from caffeine?

It is a related purine alkaloid, but its evidence base is far thinner: three small human RCTs versus decades of caffeine research. In a 4-week trial at 100–150mg/day it caused no clinically significant heart rate or blood pressure change, and in the one cognition trial it improved self-rated energy and mood but not objective test performance. No trial has compared its onset, duration or sleep effects head-to-head with caffeine.

Does Dynamine build tolerance like caffeine?

Unknown. No study has measured tolerance to methylliberine; the 4-week trial measured safety markers, not whether effects fade. Claims of "minimal tolerance" are not supported by any published trial.

Can I buy Dynamine on its own?

Not easily. Dynamine (methylliberine) is a trademarked ingredient from Compound Solutions and is primarily available in pre-formulated stacks (e.g., Thesis nootropics). Standalone Dynamine capsules are rare on the consumer market.

Is it safe to combine Dynamine with caffeine?

Yes — this is a common combination in performance supplements. Since both block adenosine, the stimulant effects are additive. Keep total combined caffeine + Dynamine intake moderate and monitor for overstimulation (anxiety, restlessness). Start with low doses of each.

Top stacks containing Dynamine (Methylliberine)

Dynamine (Methylliberine) in Southeast Asia

Products in Southeast Asia

HSA / NPRA / BPOM / FDA PH / Thai FDA

Regulatory note

Health supplements in Singapore are regulated by the Health Sciences Authority (HSA); in Malaysia by the National Pharmaceutical Regulatory Agency (NPRA); in Indonesia by the Badan Pengawas Obat dan Makanan (BPOM); in the Philippines by FDA Philippines; in Thailand by FDA Thailand. Halal certification is required by law for supplements marketed to Indonesian consumers from 18 October 2026, regulated by the Badan Penyelenggara Jaminan Produk Halal (BPJPH); in Malaysia, products described as halal must be certified, with the Jabatan Kemajuan Islam Malaysia (JAKIM) as the certifying body. We surface certification status per product where verifiable. This page is editorial, not medical advice. Consult a qualified healthcare professional before starting any supplement.

Sources (3)expand